These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 33387733)

  • 21. Detection and quantitative analysis of two independent binding modes of a small ligand responsible for DC-SIGN clustering.
    Guzzi C; Alfarano P; Sutkeviciute I; Sattin S; Ribeiro-Viana R; Fieschi F; Bernardi A; Weiser J; Rojo J; Angulo J; Nieto PM
    Org Biomol Chem; 2016 Jan; 14(1):335-44. PubMed ID: 26611567
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A multivalent inhibitor of the DC-SIGN dependent uptake of HIV-1 and Dengue virus.
    Varga N; Sutkeviciute I; Ribeiro-Viana R; Berzi A; Ramdasi R; Daghetti A; Vettoretti G; Amara A; Clerici M; Rojo J; Fieschi F; Bernardi A
    Biomaterials; 2014 Apr; 35(13):4175-84. PubMed ID: 24508075
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis of novel DC-SIGN ligands with an alpha-fucosylamide anchor.
    Timpano G; Tabarani G; Anderluh M; Invernizzi D; Vasile F; Potenza D; Nieto PM; Rojo J; Fieschi F; Bernardi A
    Chembiochem; 2008 Aug; 9(12):1921-30. PubMed ID: 18655085
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Poly-l-lysine Glycoconjugates Inhibit DC-SIGN-mediated Attachment of Pandemic Viruses.
    Cramer J; Aliu B; Jiang X; Sharpe T; Pang L; Hadorn A; Rabbani S; Ernst B
    ChemMedChem; 2021 Aug; 16(15):2345-2353. PubMed ID: 34061468
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Semen clusterin is a novel DC-SIGN ligand.
    Sabatte J; Faigle W; Ceballos A; Morelle W; Rodríguez Rodrígues C; Remes Lenicov F; Thépaut M; Fieschi F; Malchiodi E; Fernández M; Arenzana-Seisdedos F; Lortat-Jacob H; Michalski JC; Geffner J; Amigorena S
    J Immunol; 2011 Nov; 187(10):5299-309. PubMed ID: 22013110
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Non-carbohydrate inhibitors of the lectin DC-SIGN.
    Borrok MJ; Kiessling LL
    J Am Chem Soc; 2007 Oct; 129(42):12780-5. PubMed ID: 17902657
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gold manno-glyconanoparticles: multivalent systems to block HIV-1 gp120 binding to the lectin DC-SIGN.
    Martínez-Avila O; Hijazi K; Marradi M; Clavel C; Campion C; Kelly C; Penadés S
    Chemistry; 2009 Sep; 15(38):9874-88. PubMed ID: 19681073
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low-Valent Calix[4]arene Glycoconjugates Based on Hydroxamic Acid Bearing Linkers as Potent Inhibitors in a Model of Ebola Virus Cis-Infection and HCMV-gB-Recombinant Glycoprotein Interaction with MDDC Cells by Blocking DC-SIGN.
    Chakroun K; Taouai M; Porkolab V; Luczkowiak J; Sommer R; Cheneau C; Mathiron D; Ben Maaouia MA; Pilard S; Abidi R; Mullié C; Fieschi F; Cragg PJ; Halary F; Delgado R; Benazza M
    J Med Chem; 2021 Oct; 64(19):14332-14343. PubMed ID: 34524803
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of C-type lectin-oriented surfaces for high avidity glycoconjugates: towards mimicking multivalent interactions on the cell surface.
    Porkolab V; Pifferi C; Sutkeviciute I; Ordanini S; Taouai M; Thépaut M; Vivès C; Benazza M; Bernardi A; Renaudet O; Fieschi F
    Org Biomol Chem; 2020 Jul; 18(25):4763-4772. PubMed ID: 32608454
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 1,2-Mannobioside mimic: synthesis, DC-SIGN interaction by NMR and docking, and antiviral activity.
    Reina JJ; Sattin S; Invernizzi D; Mari S; Martínez-Prats L; Tabarani G; Fieschi F; Delgado R; Nieto PM; Rojo J; Bernardi A
    ChemMedChem; 2007 Jul; 2(7):1030-6. PubMed ID: 17508368
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DCIR interacts with ligands from both endogenous and pathogenic origin.
    Bloem K; Vuist IM; van den Berk M; Klaver EJ; van Die I; Knippels LM; Garssen J; García-Vallejo JJ; van Vliet SJ; van Kooyk Y
    Immunol Lett; 2014; 158(1-2):33-41. PubMed ID: 24239607
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Docking, synthesis, and NMR studies of mannosyl trisaccharide ligands for DC-SIGN lectin.
    Reina JJ; Díaz I; Nieto PM; Campillo NE; Páez JA; Tabarani G; Fieschi F; Rojo J
    Org Biomol Chem; 2008 Aug; 6(15):2743-54. PubMed ID: 18633532
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High glucose disrupts oligosaccharide recognition function via competitive inhibition: a potential mechanism for immune dysregulation in diabetes mellitus.
    Ilyas R; Wallis R; Soilleux EJ; Townsend P; Zehnder D; Tan BK; Sim RB; Lehnert H; Randeva HS; Mitchell DA
    Immunobiology; 2011; 216(1-2):126-31. PubMed ID: 20674073
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dissecting Multivalent Lectin-Carbohydrate Recognition Using Polyvalent Multifunctional Glycan-Quantum Dots.
    Guo Y; Nehlmeier I; Poole E; Sakonsinsiri C; Hondow N; Brown A; Li Q; Li S; Whitworth J; Li Z; Yu A; Brydson R; Turnbull WB; Pöhlmann S; Zhou D
    J Am Chem Soc; 2017 Aug; 139(34):11833-11844. PubMed ID: 28786666
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Designing nanomolar antagonists of DC-SIGN-mediated HIV infection: ligand presentation using molecular rods.
    Ordanini S; Varga N; Porkolab V; Thépaut M; Belvisi L; Bertaglia A; Palmioli A; Berzi A; Trabattoni D; Clerici M; Fieschi F; Bernardi A
    Chem Commun (Camb); 2015 Mar; 51(18):3816-9. PubMed ID: 25648900
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Unprecedented Thiacalixarene Fucoclusters as Strong Inhibitors of Ebola cis-Cell Infection and HCMV-gB Glycoprotein/DC-SIGN C-type Lectin Interaction.
    Taouai M; Porkolab V; Chakroun K; Cheneau C; Luczkowiak J; Abidi R; Lesur D; Cragg PJ; Halary F; Delgado R; Fieschi F; Benazza M
    Bioconjug Chem; 2019 Apr; 30(4):1114-1126. PubMed ID: 30912645
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New branched amino acids for high affinity dendrimeric DC-SIGN ligands.
    Cattiaux L; Porkolab V; Fieschi F; Mallet JM
    Bioorg Med Chem; 2018 Mar; 26(5):1006-1015. PubMed ID: 29428526
    [TBL] [Abstract][Full Text] [Related]  

  • 38. AFM force spectroscopy reveals how subtle structural differences affect the interaction strength between Candida albicans and DC-SIGN.
    te Riet J; Reinieren-Beeren I; Figdor CG; Cambi A
    J Mol Recognit; 2015 Nov; 28(11):687-98. PubMed ID: 26011000
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mannose glycoconjugates functionalized at positions 1 and 6. Binding analysis to DC-SIGN using biosensors.
    Reina JJ; Maldonado OS; Tabarani G; Fieschi F; Rojo J
    Bioconjug Chem; 2007; 18(3):963-9. PubMed ID: 17348701
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetically-encoded fragment-based discovery of glycopeptide ligands for DC-SIGN.
    Ng S; Bennett NJ; Schulze J; Gao N; Rademacher C; Derda R
    Bioorg Med Chem; 2018 Oct; 26(19):5368-5377. PubMed ID: 30344001
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.